Citius Oncology (CTOR) Accounts Payables (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Accounts Payables of $2.2 million for Q1 2026, down 71.34% year-over-year from $7.7 million in Q1 2025, and down 18.52% quarter-over-quarter from $2.7 million in Q4 2025.
Citius Oncology (CTOR) Accounts Payables (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Accounts Payables for 4 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables fell 71.34% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 71.34% YoY), while the FY2025 annual figure was $13.2 million, up 256.57% from the prior year.
- Accounts Payables eased to $2.2 million in Q1 2026 per CTOR's latest filing, from $2.7 million in the prior quarter.
- Across five years, Accounts Payables topped out at $13.2 million in Q3 2025 and bottomed at $1.3 million in Q3 2023.
- Historically, Accounts Payables has averaged $5.7 million across 4 years, with a median of $4.8 million in 2024.
- Annual changes were most pronounced in 2025 — Accounts Payables jumped 256.57% — and 2026, when it slumped 71.34%.
- Citius Oncology's Accounts Payables stood at $1.3 million in 2023, then jumped by 355.73% to $5.9 million in 2024, then tumbled by 54.04% to $2.7 million in 2025, then slipped by 18.52% to $2.2 million in 2026.
- Business Quant data shows CTOR's Accounts Payables at $2.2 million in Q1 2026, $2.7 million in Q4 2025, and $13.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Citius Oncology | 80.25 Mn | 80.25 Mn | 1.00 Mn | 7.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 13.23 Mn |
| Jun 30, 2025 | 8.67 Mn |
| Mar 31, 2025 | 7.68 Mn |
| Dec 31, 2024 | 5.87 Mn |
| Sep 30, 2024 | 3.71 Mn |
| Sep 30, 2023 | 1.29 Mn |